KKKatla Kristjansdottir

Katla Kristjansdottir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katla Kristjansdottir has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sequence variants affecting fetal globin expression pointing to potential drug targets

    by Magnus Magnusson, Gudjon Oskarsson, Sarnaver Mwende, Katla Kristjansdottir, Asgeir Sigurdsson, Matthias Valdimarsson, Olafur Stefansson, Gisli Halldorsson, Garðar Sveinbjornsson, Vinicius Tragante, et al.

    High fetal hemoglobin level is the most important predictor of favorable clinical outcome in sickle cell disease. We carried out a genome-wide association study (GWAS) on estimated fetal beta globin RNA expression ratio (FGR) using blood RNA sequence data from 22,093 adult Icelanders. In addition to the well-known BCL11A, HBB/HBG2 and HBS1L-MYB loci, we found 33 loci associated with FGR conditioned on variants at these 3 loci (cFGR). We identified fourteen candidate causal genes at the 33 loci. In the ZBTB7A, GFI1B, ZFPM1, and ALAS2 genes we identified rare loss-of-function variants that associate with large effect on cFGR. A rare variant in ZBTB7A, which had the largest increasing effect on cFGR, generates an alternative upstream inframe ATG in an erythroid specific transcript encoding an addition of 119 amino acids to the protein, highlighting a potential therapeutic target. Furthermore, rare variants with large effects in ALAS2 and GFI1B implicate the heme biosynthesis pathway and isoform specific role of GFI1B in fetal hemoglobin regulation.

  • Open Access

    A partial loss-of-function variant in STAT6 protects against type 2 asthma

    by Katla Kristjansdottir, Gudmundur L. Norddahl, Erna V. Ivarsdottir, Gisli H. Halldorsson, Gudmundur Einarsson, Kristbjorg Bjarnadottir, Gudrun Rutsdottir, Asgeir O. Arnthorsson, Christian Erikstrup, Steinunn Gudmundsdottir, et al.


  • Open Access

    Start codon variant in LAG3 is associated with decreased LAG-3 expression and increased risk of autoimmune thyroid disease

    by Saedis Saevarsdottir, Kristbjörg Bjarnadottir, Thorsteinn Markusson, Jonas Berglund, Thorunn A. Olafsdottir, Gisli H. Halldorsson, Gudrun Rutsdottir, Kristbjorg Gunnarsdottir, Asgeir Orn Arnthorsson, Sigrun H. Lund, et al.

    Autoimmune thyroid disease (AITD) is a common autoimmune disease. In a GWAS meta-analysis of 110,945 cases and 1,084,290 controls, 290 sequence variants at 225 loci are associated with AITD. Of these variants, 115 are previously unreported. Multiomics analysis yields 235 candidate genes outside the MHC-region and the findings highlight the importance of genes involved in T-cell regulation. A rare 5’-UTR variant (rs781745126-T, MAF = 0.13% in Iceland) in LAG3 has the largest effect (OR = 3.42, P = 2.2 × 10−16) and generates a novel start codon for an open reading frame upstream of the canonical protein translation initiation site. rs781745126-T reduces mRNA and surface expression of the inhibitory immune checkpoint LAG-3 co-receptor on activated lymphocyte subsets and halves LAG-3 levels in plasma among heterozygotes. All three homozygous carriers of rs781745126-T have AITD, of whom one also has two other T-cell mediated diseases, that is vitiligo and type 1 diabetes. rs781745126-T associates nominally with vitiligo (OR = 5.1, P = 6.5 × 10−3) but not with type 1 diabetes. Thus, the effect of rs781745126-T is akin to drugs that inhibit LAG-3, which unleash immune responses and can have thyroid dysfunction and vitiligo as adverse events. This illustrates how a multiomics approach can reveal potential drug targets and safety concerns.


  • Open Access

    Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture

    by Katla Kristjánsdóttir, Alexis Dziubek, Hyun Min Kang, Hojoong Kwak

    Enhancer RNAs (eRNA) are unstable non-coding RNAs, transcribed bidirectionally from active regulatory sequences, whose expression levels correlate with enhancer activity. We use capped-nascent-RNA sequencing to efficiently capture bidirectional transcription initiation across several human lymphoblastoid cell lines (Yoruba population) and detect ~75,000 eRNA transcription sites with high sensitivity and specificity. The use of nascent-RNA sequencing sidesteps the confounding effect of eRNA instability. We identify quantitative trait loci (QTLs) associated with the level and directionality of eRNA expression. High-resolution analyses of these two types of QTLs reveal distinct positions of enrichment at the central transcription factor (TF) binding regions and at the flanking eRNA initiation regions, both of which are associated with mRNA expression QTLs. These two regions—the central TF-binding footprint and the eRNA initiation cores—define a bipartite architecture of enhancers, inform enhancer function, and can be used as an indicator of the significance of non-coding regulatory variants.


  • Open Access

    Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture

    by Katla Kristjánsdóttir, Yeonui Kwak, Nathaniel D. Tippens, John T. Lis, Hyun Min Kang, Hojoong Kwak

    Enhancer RNAs (eRNA) are non-coding RNAs transcribed bidirectionally from active regulatory sequences. Their expression levels correlate with the activating potentials of the enhancers, but due to their instability, eRNAs have proven difficult to quantify in large scale. To overcome this, we use capped-nascent-RNA sequencing to efficiently capture the bidirectional initiation of eRNAs. We apply this in large scale to the human lymphoblastoid cell lines from the Yoruban population, and detected nearly 75,000 eRNA transcription sites with high sensitivity and specificity. We identify genetic variants significantly associated with overall eRNA initiation levels, as well as the transcription directionality between the two divergent eRNA pairs, namely the transcription initiation and directional initiation quantitative trait loci (tiQTLs and diQTLs) respectively. High-resolution analyses of these two types of eRNA QTLs reveal distinct positions of enrichment not only at the central transcription factor (TF) binding regions but also at the flanking eRNA initiation regions, both of which are equivalently associated with mRNA expression QTLs. These two regions - the central TF binding footprint and the eRNA initiation cores - define the bipartite architecture and the function of enhancers, and may provide further insights into interpreting the significance of non-coding regulatory variants.


  • Open Access

    Systematic analysis of the Hmga2 3′ UTR identifies many independent regulatory sequences and a novel interaction between distal sites

    by Katla Kristjánsdóttir, Elizabeth A. Fogarty, Andrew Grimson

    The 3′ untranslated regions (3′ UTRs) of mRNAs regulate transcripts by serving as binding sites for regulatory factors, including microRNAs and RNA binding proteins. Binding of such trans-acting factors can control the rates of mRNA translation, decay, and other aspects of mRNA biology. To better understand the role of 3′ UTRs in gene regulation, we performed a detailed analysis of a model mammalian 3′ UTR, that of Hmga2, with the principal goals of identifying the complete set of regulatory elements within a single 3′ UTR, and determining the extent to which elements interact with and affect one another. Hmga2 is an oncogene whose overexpression in cancers often stems from mutations that remove 3′-UTR regulatory sequences. We used reporter assays in cultured cells to generate maps of cis-regulatory information across the Hmga2 3′ UTR at different resolutions, ranging from 50 to 400 nt. We found many previously unidentified regulatory sites, a large number of which were up-regulating. Importantly, the overall location and impact of regulatory sites was conserved between different species (mouse, human, and chicken). By systematically comparing the regulatory impact of 3′-UTR segments of different sizes we were able to determine that the majority of regulatory sequences function independently; only a very small number of segments showed evidence of any interactions. However, we discovered a novel interaction whereby terminal 3′-UTR sequences induced internal up-regulating elements to convert to repressive elements. By fully characterizing one 3′ UTR, we hope to better understand the principles of 3′-UTR-mediated gene regulation.